JSPR

NASDAQStock

Jasper Therapeutics, Inc.

$1.22-0.05 (-3.94%)

52-Week Range

$1.14

$6.82

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

3.12

Volume

357.5K

Avg Volume

337.3K

Performance

+8.55%

-22.56%

-46.64%

YTD

-30.98%

-76.87%

-93.32%

-98.96%

Price Chart

ETF Exposure

JSPR is held by 8 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
IWC	iShares Micro-Cap ETF	0.01%	68,667	$92K	$1.27B	0.60%
VXF	Vanguard Extended Market ETF	0.00%	312,032	$462K	$84.10B	0.05%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	41	$82	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	1,463	$3K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	7	$14	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	833,391	$1.2M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	4,383	$9K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	377	$757	$1.29B	0.17%

About JSPR ETF Exposure

Jasper Therapeutics, Inc. (JSPR) is held by 8 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $1.22. Investors can gain exposure to JSPR through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold JSPR, sorted by portfolio weight.